Clinical Trials Browser

Interventional × nintedanib × 90 days × Clear all

NCT01658462 2026-03-16

VAROCE

Phase 2 Completed

Breast Neoplasms

NCT03377023 2026-01-22

Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer

Phase 1/2 Active not recruiting

66 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung

NCT02856425 2026-01-20

PEMBIB

Phase 1 Completed

Other solid neoplasm

Patients With Any Advanced Solid Tumors